Integrated BioPharma, Inc. (INBP) FY26 Revenue Falls 19%, Turns to Loss
Integrated BioPharma reported FY26 revenue of $43.9M, down 19.3% YoY, and an operating loss of ~$2.7M vs. $2.0M income in FY25. Q4 revenue was $9.8M, down 31.0% YoY, with a net loss of ~$1.4M.Material DetailsContext by AI AnalystThis is a negative inflection, moving from prior profitability to loss…